Elanco Animal Health (ELAN) Cash from Investing Activities (2017 - 2026)

Elanco Animal Health (ELAN) has 10 years of Cash from Investing Activities data on file, last reported at -$60.0 million in Q1 2026.

• Quarterly Cash from Investing Activities fell 3.45% year-over-year to -$60.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$281.0 million (down 126.43% YoY) and the FY2025 annual result came in at -$279.0 million, down 124.09% from the prior year.
• Cash from Investing Activities climbed to -$60.0 million in Q1 2026 per ELAN's latest filing, from -$64.0 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $1.2 billion in Q3 2024, with the low at -$101.0 million in Q3 2025.
• Average Cash from Investing Activities over 5 years is $27.7 million, with a median of -$43.0 million recorded in 2023.
• Year-over-year, Cash from Investing Activities plunged 390.0% in 2022 and jumped 3555.56% in 2024.
• Elanco Animal Health's Cash from Investing Activities stood at -$76.0 million in 2022, then jumped by 53.95% to -$35.0 million in 2023, then tumbled by 157.14% to -$90.0 million in 2024, then climbed by 28.89% to -$64.0 million in 2025, then climbed by 6.25% to -$60.0 million in 2026.
• Business Quant data shows ELAN's Cash from Investing Activities at -$60.0 million in Q1 2026, -$64.0 million in Q4 2025, and -$101.0 million in Q3 2025.